Menu

Elicio Therapeutics, Inc. ELTX

Full chart Compare
Set alert

Price alert · ELTX

All alert types
1.51 USD +0.11 (+7.86%)

At closeNov 6, 2026, 4:00 PM EST

1.48 -0.03 -1.99%

After hours · Nov 6, 4:00 PM ET

1.25 Day range 1.52
1.40 52-week range 14.85
YTD
-81.03%
1 year
-83.35%

Revenue & Expenses

Other Income → Expenses: $13.78MExpenses → Selling, General & Admin: $17.78MExpenses → Research & Development: $48.61MExpenses → Interest Expense: $876.44KGross Profit → Expenses: $27.08MRevenue → Gross Profit: $27.08MRevenue → Cost of Revenue: $1.23MNet Loss → Expenses: $26.40MOther Income$13.78MGross Profit$27.08MNet Loss$26.40MCost of Revenue$1.23MExpenses$67.26MSelling, General & Admin$17.78MResearch & Development$48.61MInterest Expense$876.44KRevenue$28.31M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ELTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-37.71M-44.99M-35.74M-23.73M-39.31M
-39.57M-51.90M-35.20M-28.21M-54.57M
-2.58-4.25-6.96-89.27-19.30
ELTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
18.56M18.80M13.62M7.80M88.76M
25.86M28.18M27.15M22.66M96.51M
24.23M39.49M15.77M13.75M15.01M
14.51M26.04M6.92M7.48M4.66M
1.64M-11.31M11.37M-102.14M81.51M
ELTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-36.95M-37.07M-32.69M-22.18M-52.64M
-16.00K-84.00K-32.00K-654.00K-382.00K
36.70M42.32M38.61M21.20M107.17M
-16.00K-84.00K-32.00K-654.00K-382.00K
-225.00K5.19M5.89M-1.63M54.15M